The Greenrose

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch The Greenrose and buy or sell other stocks, ETFs, and their options commission-free!

About GNRSQ

The Greenrose Holding Co., Inc. engages in the manufacture and processing of cannabis and cannabinoid-based products for the medical cannabis marketplace. The company was founded on August 26, 2019 and is headquartered in Amityville, NY. 

CEO
Nicole Conboy
CEONicole Conboy
Employees
Employees
Headquarters
Amityville, New York
HeadquartersAmityville, New York
Founded
2019
Founded2019
Employees
Employees

GNRSQ Key Statistics

Market cap
1.77K
Market cap1.77K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.50
Average volume2.50
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.20
52 Week high$0.20
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, The Greenrose(GNRSQ) shares are valued at $0.00. The company's market cap stands at 1.77K.

On 2026-03-14, The Greenrose(GNRSQ) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.5.

Over the past 52 weeks, The Greenrose(GNRSQ) stock has traded between a high of $0.20 and a low of $0.00.

Over the past 52 weeks, The Greenrose(GNRSQ) stock has traded between a high of $0.20 and a low of $0.00.

People also own

Based on the portfolios of people who own GNRSQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.